Hepzato is part of the
Alkylating Drugs class and treats
Melanoma.
Alkylating drugs are used to treat
brain tumors, melanoma, Hodgkin's disease, Non-Hodgkin's
lymphoma,
breast cancer,
ovarian cancer,
neuroblastoma,
leukemia,
multiple myeloma,
retinoblastoma, and
prostate cancer. They work by inhibiting cancer cell growth and slowing it down. Hepzato is only available as a brand name drug.